Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Media
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsShorts
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

Salman Fazal, MD, West Penn Hospital

Advertisement

Articles by Salman Fazal, MD, West Penn Hospital

Treatment Approach Amid COVID-19 Pandemic

ByGary Schiller, MD, UCLA Medical Center,Salman Fazal, MD, West Penn Hospital
August 20th 2020

Novel Agents for BPDCN Management

ByGary Schiller, MD, UCLA Medical Center,Salman Fazal, MD, West Penn Hospital
August 20th 2020

Second-Line Treatment Options

ByGary Schiller, MD, UCLA Medical Center,Salman Fazal, MD, West Penn Hospital
August 20th 2020

Standard of Care for BPDCN Treatment

ByGary Schiller, MD, UCLA Medical Center,Salman Fazal, MD, West Penn Hospital
August 20th 2020

BPDCN Prevalence, Patient Profile, and Work-Up

ByGary Schiller, MD, UCLA Medical Center,Salman Fazal, MD, West Penn Hospital
August 20th 2020
Advertisement

Latest Updated Articles

  • Standard of Care for BPDCN Treatment
    Standard of Care for BPDCN Treatment

    August 20th 2020

  • Novel Agents for BPDCN Management
    Novel Agents for BPDCN Management

    August 20th 2020

  • Treatment Approach Amid COVID-19 Pandemic
    Treatment Approach Amid COVID-19 Pandemic

    August 20th 2020

  • Second-Line Treatment Options
    Second-Line Treatment Options

    August 20th 2020

  • BPDCN Prevalence, Patient Profile, and Work-Up
    BPDCN Prevalence, Patient Profile, and Work-Up

    August 20th 2020



Advertisement
Advertisement

Trending on OncLive

1

Breast Cancer Experts Spotlight Practice-Informing and Thought-Provoking Data From ASCO 2026

2

FDA Grants Priority Review to Giredestrant for ER-Positive Early Breast Cancer

3

CELMoDs and Bispecifics Break Through Across Lymphomas and Leukemias at EHA 2026

4

Bispecific-Based Approaches Highlight Key Multiple Myeloma Data Set to Emerge at EHA 2026

5

From Toilet Cleaner to Thoracic Oncologist and Patient: How Ross Camidge Built a Life Worth Loving

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us